Medicare Price Cuts on 10 Drugs, Biggest 79% Drop This Year
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Side-by-side look at the strengths and weaknesses of zero-based budgeting and envelope systems to help you decide which suits your goals.
28,655 articlesMedicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
GPIQ carries the lowest fee in the Nasdaq-100 income ETF group, at 0.29%, intensifying the debate over cost versus yi...
As volatility lingers into 2026, a three-rule framework offers a straightforward path to better risk-adjusted returns...
The Federal Reserve is anticipated to keep the federal funds rate unchanged as Powell nears the end of his chair tenu...
AMD CEO Lisa Su addressed MIT Class of 2026 graduates with a call to apply AI with purpose and judgment, signaling ho...
Fomo has closed a $75 million Series B round led by Index Ventures, pushing the company’s valuation to $550 million a...
U.S. oil refiners are set for a historic profit surge as supply disruptions and stronger demand push refining margins...
A quiet shift in hiring is underway as AI screens candidates more aggressively. Experts warn of the invisible layoff:...
Hut 8 and Riot Platforms jump as Bitcoin miners pivot to AI infrastructure, signaling a new revenue model powered by ...
A government-backed move accelerates commercialization of quantum tech, and three ETFs are steering investors through...
A California adviser is deepening collaboration between financial advisers and reverse mortgage lenders to integrate ...
A veteran investor casts Broadcom as a core AI winner, arguing durable AI demand and strategic partnerships could kee...